{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:45:28Z","timestamp":1761698728576,"version":"build-2065373602"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,28]]},"DOI":"10.7759\/cureus.95618","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T20:56:03Z","timestamp":1761684963000},"source":"Crossref","is-referenced-by-count":0,"title":["Hypoalbuminemia and Nutritional Status in Docetaxel-Induced Erythema Multiforme: A Case Report"],"prefix":"10.7759","author":[{"given":"Aisha","family":"Nadeem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abel","family":"Zachariah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cden.2013.07.001","article-title":"Erythema multiforme: a review of epidemiology, pathogenesis, clinical features, and treatment","volume":"57","author":"Samim F","year":"2013","unstructured":"Samim F, Auluck A, Zed C, Williams PM. Erythema multiforme: a review of epidemiology, pathogenesis, clinical features, and treatment. Dent Clin North Am. 2013, 57:583-96. 10.1016\/j.cden.2013.07.001","journal-title":"Dent Clin North Am"},{"key":"ref2","unstructured":"Docetaxel 20 mg\/ml concentrate for solution for infusion. (2024). Accessed. 2025 Sept 24: https:\/\/www.medicines.org.uk\/emc\/files\/pil.7206.pdf."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-004-0643-9","article-title":"Erythema multiforme major following docetaxel","volume":"271","author":"Moisidis C","year":"2005","unstructured":"Moisidis C, M\u00f6bus V. Erythema multiforme major following docetaxel. Arch Gynecol Obstet. 2005, 271:267-9. 10.1007\/s00404-004-0643-9","journal-title":"Arch Gynecol Obstet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00120-007-1367-9","article-title":"[Lethal course after chemotherapy with docetaxel. Acute liver failure with accompanying erythema multiforme major]","volume":"46","author":"Ohlmann CH","year":"2007","unstructured":"Ohlmann CH, Kohlmorgen S, Sahi D, Engelmann U, Heidenreich A. [Lethal course after chemotherapy with docetaxel. Acute liver failure with accompanying erythema multiforme major]. Urologe A. 2007, 46:1425-7. 10.1007\/s00120-007-1367-9","journal-title":"Urologe A"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7928752","article-title":"Docetaxel-induced Stevens-Johnson syndrome in a patient with metastatic prostate adenocarcinoma","volume":"2019","author":"Diab O","year":"2019","unstructured":"Diab O, Mcentire D, Kassim T, et al.. Docetaxel-induced Stevens-Johnson syndrome in a patient with metastatic prostate adenocarcinoma. Case Rep Oncol Med. 2019, 2019:7928752. 10.1155\/2019\/7928752","journal-title":"Case Rep Oncol Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/1078155208096111","article-title":"Cutaneous reaction associated with weekly docetaxel administration","volume":"15","author":"Chew L","year":"2009","unstructured":"Chew L, Chuen VS. Cutaneous reaction associated with weekly docetaxel administration. J Oncol Pharm Pract. 2009, 15:29-34. 10.1177\/1078155208096111","journal-title":"J Oncol Pharm Pract"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.136025","article-title":"Docetaxel induced Lyell's syndrome: a rare life threatening cause of dermatitis medicamentosas","volume":"10","author":"Arshad F","year":"2014","unstructured":"Arshad F, Bhat TS, Lone AR. Docetaxel induced Lyell's syndrome: a rare life threatening cause of dermatitis medicamentosas. J Cancer Res Ther. 2014, 10:742-4. 10.4103\/0973-1482.136025","journal-title":"J Cancer Res Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/BF00210785","article-title":"Docetaxel serum protein binding with high affinity to alpha 1-acid glycoprotein","volume":"14","author":"Urien S","year":"1996","unstructured":"Urien S, Barr\u00e9 J, Morin C, Paccaly A, Montay G, Tillement JP. Docetaxel serum protein binding with high affinity to alpha 1-acid glycoprotein. Invest New Drugs. 1996, 14:147-51. 10.1007\/BF00210785","journal-title":"Invest New Drugs"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.05.011","article-title":"Chemotherapy dose intensity predicted by baseline nutrition assessment in gastrointestinal malignancies: a multicentre analysis","volume":"63","author":"Klute KA","year":"2016","unstructured":"Klute KA, Brouwer J, Jhawer M, et al.. Chemotherapy dose intensity predicted by baseline nutrition assessment in gastrointestinal malignancies: a multicentre analysis. Eur J Cancer. 2016, 63:189-200. 10.1016\/j.ejca.2016.05.011","journal-title":"Eur J Cancer"},{"key":"ref10","unstructured":"Systemic anti-cancer therapy protocol. docetaxel, trastuzumab, pertuzumab with paclitaxel alternative for advanced breast cancer. (2025). Accessed: 2025 Sept 24: https:\/\/www.clatterbridgecc.nhs.uk\/application\/files\/1017\/4126\/0801\/Docetaxel_and_HP_with_Paclitaxel_Alternative_Adva...."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.39797","article-title":"A rare case of pertuzumab-induced toxic epidermal necrolysis","volume":"15","author":"Mohamed Jiffry MZ","year":"2023","unstructured":"Mohamed Jiffry MZ, Carmona Pires F, Perozo MA, Rangsipat N, Tabares D. A rare case of pertuzumab-induced toxic epidermal necrolysis. Cureus. 2023, 15:e39797. 10.7759\/cureus.39797","journal-title":"Cureus"},{"key":"ref12","article-title":"Adverse drug reaction probability scale (Naranjo) in drug-induced liver injury","author":"National Institute of Diabetes and Digestive and Kidney Diseases","year":"2012","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases. Adverse drug reaction probability scale (Naranjo) in drug-induced liver injury. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda; 2012."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2006.00166.x","article-title":"Pharmacokinetics and pharmacodynamics of protein-unbound docetaxel in cancer patients","volume":"97","author":"Minami H","year":"2006","unstructured":"Minami H, Kawada K, Sasaki Y, et al.. Pharmacokinetics and pharmacodynamics of protein-unbound docetaxel in cancer patients. Cancer Sci. 2006, 97:235-41. 10.1111\/j.1349-7006.2006.00166.x","journal-title":"Cancer Sci"},{"key":"ref14","article-title":"Alpha-1-acid glycoprotein as an independent predictor for treatment effects and a prognostic factor of survival in patients with non-small cell lung cancer treated with docetaxel","volume":"9","author":"Bruno R","year":"2003","unstructured":"Bruno R, Olivares R, Berille J, et al.. Alpha-1-acid glycoprotein as an independent predictor for treatment effects and a prognostic factor of survival in patients with non-small cell lung cancer treated with docetaxel. Clin Cancer Res. 2003, 9:1077-82.","journal-title":"Clin Cancer Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-50","article-title":"Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study","volume":"10","author":"Arrieta O","year":"2010","unstructured":"Arrieta O, Michel Ortega RM, Villanueva-Rodr\u00edguez G, et al.. Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC Cancer. 2010, 10:50. 10.1186\/1471-2407-10-50","journal-title":"BMC Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32718","article-title":"Associations between nutritional factors and chemotherapy toxicity in older adults with solid tumors","volume":"126","author":"Dotan E","year":"2020","unstructured":"Dotan E, Tew WP, Mohile SG, et al.. Associations between nutritional factors and chemotherapy toxicity in older adults with solid tumors. Cancer. 2020, 126:1708-16. 10.1002\/cncr.32718","journal-title":"Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/427841-hypoalbuminemia-and-nutritional-status-in-docetaxel-induced-erythema-multiforme-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T20:56:04Z","timestamp":1761684964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/427841-hypoalbuminemia-and-nutritional-status-in-docetaxel-induced-erythema-multiforme-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.95618","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,28]]}}}